文献速递肾移植慢性肾脏病

肾移植术后1年肾性骨营养不良的模式

Patterns of renal osteodystrophy 1 year after kidney transplantation.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

本研究对141例未选择的肾移植受者进行观察性队列研究,术后1年行髂骨活检和双能X线吸收测定。结果显示71%患者骨转换正常,26%低骨转换,仅3%高骨转换;16%存在骨矿化延迟,骨质疏松患病率15-46%。

要点

  • 肾移植术后1年多数受者骨转换正常,低骨转换占26%,高骨转换罕见。
  • 骨矿化延迟占16%,与甲状旁腺功能亢进、高磷排泄和低磷血症相关。
  • 骨质疏松患病率15-46%,与骨转换和矿化状态无关。

核心结论

  • 多数肾移植受者术后1年骨转换正常,包括骨质疏松患者。
  • 低骨转换见于相当一部分患者,高骨转换罕见。
  • 维生素D缺乏和低磷血症是改善移植后骨健康的潜在干预靶点。

研究设计与样本

  • 观察性队列研究,纳入141例未选择的肾移植受者。
  • 术后1年进行髂骨活检和双能X线吸收测定,同时收集血和24小时尿样。

主要发现

  • 骨转换正常占71%,低骨转换占26%,高骨转换仅4例(3%)。
  • 甲状旁腺功能亢进伴高钙血症占13%,其中仅1例骨转换高。
  • 骨矿化延迟占16%,其特征为甲状旁腺激素137 vs 53 ρg/mL、磷排泄分数40 vs 32%、血磷2.68 vs 3.18 mg/dL、骨化二醇29 vs 37 ng/mL(与矿化正常者比较)。
  • 骨质疏松患病率15-46%,远端骨骼患病率最高。
  • 骨质疏松比例在各骨转换和矿化类别间相当。

临床怎么用

  • 肾移植术后1年应评估骨转换状态,避免仅凭骨质疏松诊断即认为高转换。
  • 对低骨转换患者需谨慎解读骨质疏松,并考虑骨活检明确。
  • 监测和纠正维生素D缺乏及低磷血症可能改善骨健康。

局限性

  • 观察性研究,无法推断因果关系。
  • 样本为未选择的白种人群,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal osteodystrophy is considered common, but is not well characterized in contemporary kidney transplant recipients. This study reports extensively on bone phenotype by bone histomorphometry, bone densitometry and novel bone biomarkers 1 year after kidney transplantation. METHODS: A transiliac bone biopsy and dual-energy X-ray absorptiometry scans were performed in 141 unselected kidney transplant recipients in this observational cohort study. Blood and 24-h urine samples were collected simultaneously. RESULTS: The median age was 57 ± 11 years, 71% were men and all were of Caucasian ethnicity. Bone turnover was normal in 71% of patients, low in 26% and high in just four cases (3%). Hyperparathyroidism with hypercalcaemia was present in 13% of patients, of which only one had high bone turnover. Delayed bone mineralization was detected in 16% of patients, who were characterized by hyperparathyroidism (137 versus 53 ρg/mL), a higher fractional excretion of phosphate (40 versus 32%) and lower levels of phosphate (2.68 versus 3.18 mg/dL) and calcidiol (29 versus 37 ng/mL) compared with patients with normal bone mineralization. Osteoporosis was present in 15-46% of patients, with the highest prevalence at the distal skeleton. The proportion of osteoporotic patients was comparable across categories of bone turnover and mineralization. CONCLUSIONS: The majority of kidney transplant recipients, including patients with osteoporosis, have normal bone turnover at 1-year post-transplant. Low bone turnover is seen in a substantial subset, while high bone turnover is rare. Vitamin D deficiency and hypophosphataemia represent potential interventional targets to improve bone health post-transplant.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Jørgensen HS, Behets G, Bammens B, et al. Patterns of renal osteodystrophy 1 year after kidney transplantation. Nephrol Dial Transplant. 2021. PMID: 34383929. doi:10.1093/ndt/gfab239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。